Skip to main content
GutCited

Butyrate (Sodium/Calcium Butyrate) Şekiller

89 hakemli araştırmalardan görseller

Tümü Psyllium Husk Bifidobacterium lactis Fructooligosaccharides (FOS) Lactobacillus plantarum Peppermint Oil Pancreatic Enzymes (Pancrelipase) Curcumin Vitamin A Medium-Chain Triglycerides (MCT Oil) Galactooligosaccharides (GOS) Lactobacillus gasseri Aloe Vera (Inner Leaf Gel) Alpha-Galactosidase Vitamin D L-Glutamine Inulin Ginger Lactase Berberine Omega-3 Fatty Acids (EPA/DHA) Bovine Colostrum Zinc Bifidobacterium bifidum Butyrate (Sodium/Calcium Butyrate) Bacillus coagulans Saccharomyces boulardii Lactobacillus acidophilus N-Acetyl Cysteine (NAC) Bifidobacterium longum
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Fig 2. Comparison of fecal microbiota in congenital chloride diarrhea (CLD), CLD-associated inflammatory bowel disease (CLD IBD), Crohn’s disease (CD), and healthy controls. Shown are Principal-coordinate Analysis (PcoA) plots based on Bray-Curtis dissimi
Figure 3

Fig 2. Comparison of fecal microbiota in congenital chloride diarrhea (CLD), CLD-associated inflammatory bowel disease (CLD IBD), Crohn’s disease (CD), and healthy controls. Shown are Principal-coordinate Analysis (PcoA) plots based …

Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease.

Fig 3. Microbiota composition in congenital chloride diarrhea (CLD), CLD-associated IBD (CLD IBD), Crohn’s disease (CD), and healthy controls. Shown are family-level microbiota composition for the taxa with significant differences (P<0.01) between CLD
Figure 4

Fig 3. Microbiota composition in congenital chloride diarrhea (CLD), CLD-associated IBD (CLD IBD), Crohn’s disease (CD), and healthy controls. Shown are family-level microbiota composition for the taxa with significant differences …

Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease.

Figure 5
Figure 5

Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease.

Figure 6
Figure 6 Chart

Experimental results examining effect of Nuts on Gastrointestinal Health, with data points illustrating key findings related to nuts are high nutrient-dense foods containing healthy lipids, dietary fiber, and bioactive phytochemicals, including .

Effect of Nuts on Gastrointestinal Health.

Figure 1. Effects of C. butyricum and 25-hydroxyvitamin D3 on the latency-to-lie time, tibial content of calcium and phosphorus, BMD and bone-breaking strengthen of broilers. (A) LTL. (B) calcium. (C) phosphorus. (D) BMD. (E) bone-breaking strengthen. (F)
Figure 1 Chart

Effects of dietary Clostridium butyricum and 25-hydroxyvitamin D3 supplementation on latency-to-lie time in a poultry model, indicating improvements in leg health and bone strength.

Dietary Clostridium butyricum and 25-Hydroxyvitamin D3 modulate bone metabolism of broilers through …

Figure 2
Figure 2 Chart

Experimental data from a study on dietary Clostridium butyricum and 25-hydroxyvitamin D3 and their combined effects on bone metabolism through gut microbiota modulation in poultry.

Dietary Clostridium butyricum and 25-Hydroxyvitamin D3 modulate bone metabolism of broilers through …

Figure 4. Effects of Clostridium butyricum and 25-hydroxyvitamin D3 on the hypothalamic and intestinal brain-gut peptides in broilers. (A) Caecal 5-HT content. (B) Caecal DA content. (C) Caecal GLP-1 content. (D) Ileal PYY content. (E) Hypothalamic 5-HT c
Figure 3 Chart

Hypothalamic signaling pathway analysis in poultry fed Clostridium butyricum and 25-hydroxyvitamin D3, examining effects on bone metabolism regulatory mechanisms.

Dietary Clostridium butyricum and 25-Hydroxyvitamin D3 modulate bone metabolism of broilers through …

Figure 5. Effects of Clostridium butyricum and 25-hydroxyvitamin D3 on caecal SCFAs in broilers. (A) acetic acid level. (B) propionic acid level. (C) isobutyric level. (D) butyric level. (E) isovaleric level. (F) valeric level. Con birds fed basal diet wi
Figure 4 Chart

Caecal short-chain fatty acid (SCFA) concentrations in poultry supplemented with Clostridium butyricum and 25-hydroxyvitamin D3, linking gut fermentation products to bone metabolism modulation.

Dietary Clostridium butyricum and 25-Hydroxyvitamin D3 modulate bone metabolism of broilers through …

Figure 6. Effects of Clostridium butyricum and 25-hydroxyvitamin D3 on metagenome of broilers’ caecal microflora. (A) gene number venn graph. (B) core_Pan gene dilution curve. (C) species relative abundance histogram display based on genus level. (D) speci
Figure 5 Chart

Metagenomic analysis of caecal microbiota in poultry receiving Clostridium butyricum and 25-hydroxyvitamin D3 supplementation, revealing shifts in microbial community structure.

Dietary Clostridium butyricum and 25-Hydroxyvitamin D3 modulate bone metabolism of broilers through …

Figure 7. Effects of Clostridium butyricum and 25-hydroxyvitamin D3 on caecal microflora on genus and species levels in broilers. (A) top 12 distinguished genus based on Kruskal_Wallis analysis; (B) top 12 distinguished species based on Kruskal_Wallis anal
Figure 6 Chart

Caecal microbial composition data from poultry treated with Clostridium butyricum and 25-hydroxyvitamin D3, showing taxonomic-level changes associated with improved bone metabolism.

Dietary Clostridium butyricum and 25-Hydroxyvitamin D3 modulate bone metabolism of broilers through …

Figure 8. Effects of Clostridium butyricum and 25-hydroxyvitamin D3 on KEGG metabolic pathways of caecal microflora in broilers based on metagenomics. (A) Functional level PCA analysis. (B) Functional level PCoA analysis. (C) Heatmap of KEGG pathways. (D)
Figure 7 Chart

Metagenomic analysis of caecal microbiota in poultry receiving Clostridium butyricum and 25-hydroxyvitamin D3 supplementation, revealing shifts in microbial community structure.

Dietary Clostridium butyricum and 25-Hydroxyvitamin D3 modulate bone metabolism of broilers through …

Figure 1
Figure 1 Diagram

Identification of butyrate metabolism-related genes shared between metabolic-associated steatotic liver disease (MASLD) and colorectal cancer, using bioinformatic screening approaches.

Exploring the butyrate metabolism-related shared genes in metabolic associated steatohepatitis and ulcerative …

Figure 2
Figure 2 Chart

Gene expression analysis of butyrate metabolism-related shared genes across MASLD and colorectal cancer datasets, highlighting differential expression patterns.

Exploring the butyrate metabolism-related shared genes in metabolic associated steatohepatitis and ulcerative …

Figure 3
Figure 3 Chart

Functional enrichment analysis of the identified butyrate metabolism-related shared genes, mapping their involvement in key metabolic and immune pathways.

Exploring the butyrate metabolism-related shared genes in metabolic associated steatohepatitis and ulcerative …

Figure 4
Figure 4 Diagram

Protein-protein interaction network of butyrate metabolism-related genes implicated in both MASLD and colorectal cancer pathogenesis.

Exploring the butyrate metabolism-related shared genes in metabolic associated steatohepatitis and ulcerative …

Figure 5
Figure 5 Chart

Immune cell infiltration analysis in MASLD and colorectal cancer tissues, correlating butyrate metabolism gene expression with immune microenvironment composition.

Exploring the butyrate metabolism-related shared genes in metabolic associated steatohepatitis and ulcerative …

Figure 6
Figure 6 Chart

Diagnostic or prognostic model performance based on butyrate metabolism-related shared genes, using receiver operating characteristic curves or similar metrics.

Exploring the butyrate metabolism-related shared genes in metabolic associated steatohepatitis and ulcerative …

Figure 7
Figure 7 Chart

Correlation analysis between butyrate metabolism gene expression and clinical parameters in MASLD and colorectal cancer patient cohorts.

Exploring the butyrate metabolism-related shared genes in metabolic associated steatohepatitis and ulcerative …

Figure 8
Figure 8 Chart

Validation analysis of the butyrate metabolism-related shared gene signatures in independent MASLD and colorectal cancer datasets.

Exploring the butyrate metabolism-related shared genes in metabolic associated steatohepatitis and ulcerative …

Figure 9
Figure 9 Chart

Drug sensitivity or molecular docking analysis targeting butyrate metabolism-related genes shared between MASLD and colorectal cancer.

Exploring the butyrate metabolism-related shared genes in metabolic associated steatohepatitis and ulcerative …

Figure 10
Figure 10 Chart

Single-cell or transcriptomic subtype analysis of butyrate metabolism-related gene expression patterns in MASLD and colorectal cancer tissues.

Exploring the butyrate metabolism-related shared genes in metabolic associated steatohepatitis and ulcerative …

Figure 11
Figure 11 Chart

Supplementary bioinformatic analysis supporting the role of butyrate metabolism as a molecular link between MASLD and colorectal cancer.

Exploring the butyrate metabolism-related shared genes in metabolic associated steatohepatitis and ulcerative …

Figure 2
Figure 2

Sodium butyrate regulates macrophage polarization by TGR5/β-arrestin2 in vitro.

Figure 3
Figure 3

Sodium butyrate regulates macrophage polarization by TGR5/β-arrestin2 in vitro.

Sayfa 3 / 4